PT2970333T - Inibidores macrocíclicos de lrrk2 quinase - Google Patents
Inibidores macrocíclicos de lrrk2 quinaseInfo
- Publication number
- PT2970333T PT2970333T PT147099626T PT14709962T PT2970333T PT 2970333 T PT2970333 T PT 2970333T PT 147099626 T PT147099626 T PT 147099626T PT 14709962 T PT14709962 T PT 14709962T PT 2970333 T PT2970333 T PT 2970333T
- Authority
- PT
- Portugal
- Prior art keywords
- kinase inhibitors
- lrrk2 kinase
- macrocyclic
- macrocyclic lrrk2
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305311 | 2013-03-15 | ||
| EP13305314 | 2013-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2970333T true PT2970333T (pt) | 2017-08-01 |
Family
ID=50277239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT147099626T PT2970333T (pt) | 2013-03-15 | 2014-03-14 | Inibidores macrocíclicos de lrrk2 quinase |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20160031905A1 (pt) |
| EP (1) | EP2970333B1 (pt) |
| JP (1) | JP2016510793A (pt) |
| KR (1) | KR20150129016A (pt) |
| CN (1) | CN105143232A (pt) |
| AU (1) | AU2014230485A1 (pt) |
| BR (1) | BR112015019873A2 (pt) |
| CA (1) | CA2904462A1 (pt) |
| DK (1) | DK2970333T3 (pt) |
| EA (1) | EA201591698A1 (pt) |
| ES (1) | ES2635021T3 (pt) |
| HK (1) | HK1219481A1 (pt) |
| MX (1) | MX2015011359A (pt) |
| PL (1) | PL2970333T3 (pt) |
| PT (1) | PT2970333T (pt) |
| SG (1) | SG11201506357RA (pt) |
| TW (1) | TW201444850A (pt) |
| WO (1) | WO2014140235A1 (pt) |
| ZA (1) | ZA201506327B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150133765A (ko) * | 2013-03-15 | 2015-11-30 | 온코디자인 에스.에이. | 거대고리 rip2 키나제 억제제 |
| WO2016146651A1 (en) | 2015-03-16 | 2016-09-22 | Oncodesign Sa | Macrocyclic activin-like receptor kinase inhibitors |
| JP7092405B2 (ja) * | 2018-04-16 | 2022-06-28 | 深▲チェン▼市塔吉瑞生物医薬有限公司 | キナーゼ活性を阻害するためのジ（ヘテロ）アリール大環状化合物 |
| AU2021214866A1 (en) * | 2020-01-31 | 2022-09-22 | Oncodesign Precision Medicine (OPM) | Macrocyclic RIP2-kinase inhibitors |
| US11858940B2 (en) * | 2020-03-21 | 2024-01-02 | Arvinas Operations, Inc. | Selective modulators of mutant LRRK2 proteolysis and associated methods of use |
| BR112023012947A2 (pt) | 2021-10-27 | 2024-04-30 | H Lundbeck As | Inibidores de lrrk2 |
| WO2023222005A1 (zh) * | 2022-05-18 | 2023-11-23 | 上海翊石医药科技有限公司 | 一种芳杂环类化合物及其中间体、药物组合物和用途 |
| WO2024051631A1 (zh) * | 2022-09-07 | 2024-03-14 | 苏州朗睿生物医药有限公司 | 一种大环咪唑并[1,2-b]哒嗪衍生物及其制备方法和用途 |
| US11958865B1 (en) | 2022-09-15 | 2024-04-16 | H. Lundbeck A/S | Leucine-rich repeat kinase 2 (LRRK2) inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201008134D0 (en) * | 2010-05-14 | 2010-06-30 | Medical Res Council Technology | Compounds |
| GB201015949D0 (en) * | 2010-09-22 | 2010-11-03 | Medical Res Council Technology | Compounds |
| KR101649610B1 (ko) * | 2011-04-21 | 2016-08-19 | 오리제니스 게엠베하 | 키나아제 억제제로서의 헤테로사이클릭 화합물 |
| WO2013001310A1 (en) * | 2011-06-30 | 2013-01-03 | Centro Nacional De Investigaciones Oncológicas (Cnio) | Macrocyclic compounds and their use as cdk8 inhibitors |
| JP6082397B2 (ja) * | 2011-09-30 | 2017-02-15 | イプセン ファルマ ソシエテ パール アクシオン サンプリフィエＩｐｓｅｎ Ｐｈａｒｍａ Ｓ．Ａ．Ｓ． | マクロ環状ｌｒｒｋ２キナーゼ阻害剤 |
| BR112014007622A2 (pt) * | 2011-09-30 | 2017-04-04 | Oncodesign Sa | inibidores de flt3 cinase macrocíclicos |
-
2014
- 2014-03-14 AU AU2014230485A patent/AU2014230485A1/en not_active Abandoned
- 2014-03-14 CA CA2904462A patent/CA2904462A1/en not_active Abandoned
- 2014-03-14 WO PCT/EP2014/055049 patent/WO2014140235A1/en active Application Filing
- 2014-03-14 TW TW103109451A patent/TW201444850A/zh unknown
- 2014-03-14 EA EA201591698A patent/EA201591698A1/ru unknown
- 2014-03-14 KR KR1020157029380A patent/KR20150129016A/ko not_active Application Discontinuation
- 2014-03-14 ES ES14709962.6T patent/ES2635021T3/es active Active
- 2014-03-14 US US14/777,495 patent/US20160031905A1/en not_active Abandoned
- 2014-03-14 DK DK14709962.6T patent/DK2970333T3/en active
- 2014-03-14 MX MX2015011359A patent/MX2015011359A/es unknown
- 2014-03-14 PT PT147099626T patent/PT2970333T/pt unknown
- 2014-03-14 BR BR112015019873A patent/BR112015019873A2/pt not_active IP Right Cessation
- 2014-03-14 PL PL14709962T patent/PL2970333T3/pl unknown
- 2014-03-14 JP JP2015562173A patent/JP2016510793A/ja not_active Abandoned
- 2014-03-14 CN CN201480014168.6A patent/CN105143232A/zh active Pending
- 2014-03-14 EP EP14709962.6A patent/EP2970333B1/en not_active Not-in-force
- 2014-03-14 SG SG11201506357RA patent/SG11201506357RA/en unknown
-
2015
- 2015-08-28 ZA ZA2015/06327A patent/ZA201506327B/en unknown
-
2016
- 2016-06-28 HK HK16107521.5A patent/HK1219481A1/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2970333B1 (en) | 2017-05-03 |
| US20160031905A1 (en) | 2016-02-04 |
| EP2970333A1 (en) | 2016-01-20 |
| WO2014140235A1 (en) | 2014-09-18 |
| JP2016510793A (ja) | 2016-04-11 |
| ES2635021T3 (es) | 2017-10-02 |
| BR112015019873A2 (pt) | 2017-07-18 |
| CA2904462A1 (en) | 2014-09-18 |
| SG11201506357RA (en) | 2015-09-29 |
| DK2970333T3 (en) | 2017-08-21 |
| EA201591698A1 (ru) | 2016-02-29 |
| PL2970333T3 (pl) | 2017-12-29 |
| KR20150129016A (ko) | 2015-11-18 |
| AU2014230485A1 (en) | 2015-09-24 |
| MX2015011359A (es) | 2015-12-16 |
| ZA201506327B (en) | 2017-02-22 |
| HK1219481A1 (zh) | 2017-04-07 |
| CN105143232A (zh) | 2015-12-09 |
| TW201444850A (zh) | 2014-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1220459A1 (zh) | 激酶抑制劑 | |
| HK1214813A1 (zh) | 激酶抑制劑 | |
| ZA201603337B (en) | Pyrimidopyrimidinones useful as wee-1 kinase inhibitors | |
| HK1222387A1 (zh) | 作為 抑制劑的芳基吡咯並吡啶衍生的化合物 | |
| SG11201600062RA (en) | Pyrimidine derivatives as kinase inhibitors | |
| HK1211578A1 (en) | Amidoimidazopyridazines as mknk-1 kinase inhibitors mknk-1 | |
| HK1199838A1 (en) | Macrocyclic lrrk2 kinase inhibitors lrrk2 | |
| HK1219104A1 (zh) | 激酶抑制劑 | |
| HK1219481A1 (zh) | 大環的 激酶抑制劑 | |
| HK1219057A1 (zh) | 大環的鹽可誘導的激酶抑制劑 | |
| HK1213252A1 (zh) | 雙環二氫吡啶酮激酶抑制劑 | |
| EP3007689A4 (en) | NON-SELECTIVE KINASE INHIBITORS | |
| ZA201701841B (en) | Macrocyclic lrrk2 kinase inhibitors | |
| HK1218263A1 (zh) | 大環 激酶抑制劑 | |
| HK1222539A1 (zh) | 激酶抑制劑組合 | |
| EP2968995A4 (en) | INHIBITORS OF LRRK2 KINASE ACTIVITY | |
| EP2999472A4 (en) | INHIBITORS OF AURORA KINASE | |
| IL244029B (en) | Deoxycytodine kinase inhibitors | |
| HK1213181A1 (zh) | 雙環氧雜內酰胺激酶抑制劑 | |
| GB201307155D0 (en) | Kinase inhibitors | |
| GB201304714D0 (en) | Macrocyclic RIP2 Kinase inhibitors | |
| GB201404570D0 (en) | Macrocyclic kinase inhibitors | |
| GB201404555D0 (en) | Macrocyclic kinase inhibitors |